Cancer Diagnostic Market is expected to increase in global worth from USD $171.99 billion in 2023 to USD $280.37 billion in 2030, with a Compound Annual Growth Rate of 7.23 % between 2024-2030. This growth is contributed by raising tendencies of cancer, improvements in the diagnostic tools, and consciousness of the early identification strategies. Engaging the constant increase in demand for personalized medicine and advancement in imaging services do help in expanding the market opportunity while categorizing cancer diagnostics as an inevitable segment in healthcare for early detection and better patient outcomes.